Send the following on WhatsApp
Continue to ChatA Phase 3b, multicenter, randomized, double blind, Placebo-controlled, parallel-group trial with an open label extension phase to evaluate efficacy and safety of avatrombopag for the treatmnet of trombocytopenia in pediatric subject with immune trombocytopenia for > 6 months - https://avesis.istanbul.edu.tr/proje/06df9ff8-0cbe-4112-a68c-cd8456053760/a-phase-3b-multicenter-randomized-double-blind-placebo-controlled-parallel-group-trial-with-an-open-label-extension-phase-to-evaluate-efficacy-and-safety-of-avatrombopag-for-the-treatmnet-of-trombocytopenia-in-pediatric-subject-with-immune-trombocyto